Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors

Background: Thyroid toxicity is common following immune checkpoint inhibitor (ICI) treatment. Published studies estimate the incidence at 10-20%, although rates vary widely between different ICIs. The etiology of ICI-associated thyroid immune related adverse events (irAEs) is unknown & not all p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Muir, Christopher Alan, Menzies, Alexander M, Clifton-Bligh, Roderick John, Long, Georgina V, Scolyer, Richard A, Tsang, Venessa
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Thyroid
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265849/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1790
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires